Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.

BACKGROUND Lymphatic mapping in breast cancer performed solely by intraparenchymal injections of blue dye remains an accepted method of identifying sentinel nodes, largely because of its simplicity. As currently practiced, the technique is associated with a marked learning curve, variable identification rates of sentinel nodes, and high false-negative rates. The purpose of this study is to improve dye-only lymphatic mapping of the breast by using an alternative site for injection of blue dye: the subareolar lymphatic plexus. STUDY DESIGN In the 10 months between August 1998 and May 1999, 40 women with operable breast cancer in stages I and II underwent lymphatic mapping and sentinel node biopsy performed solely by subareolar injections of blue dye, followed by complete axillary node dissection. The technique involved the injection of 5 mL of 1% isosulfan blue into the subareolar plexus, which consists of breast tissue located immediately beneath the areola. No peritumoral injections of blue dye were performed. The ability of subareolar dye injections to identify sentinel nodes and accurately predict the pathologic status of the axilla was determined and compared with published results for dye-only lymphatic mapping using intraparenchymal injections. RESULTS The identification rate of sentinel nodes was 98% (in 39 of 40 patients). Axillary basins harboring positive lymph nodes were found in 15 of these 39 patients (38.5%). Sentinel nodes correctly predicted the status of these 15 positive axillary basins in 100% of the patients. There were no false-negative sentinel node biopsies, indicating a false-negative rate of 0 (in 0 of 15). The overall accuracy, sensitivity, and specificity were 100%. CONCLUSIONS Compared with other series of dye-directed lymphatic mapping, the present study of dye-only injections into the subareolar plexus demonstrates a high sentinel node identification rate, absent false-negative rate, and rapid learning curve. On the basis of these findings, we propose that injections into the subareolar lymphatic plexus are the optimal way to perform dye-only lymphatic mapping of the breast.

[1]  P. Stanton,et al.  Sentinel node localization in patients with breast cancer , 1998, The British journal of surgery.

[2]  A E Giuliano,et al.  Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. , 1998, The New England journal of medicine.

[3]  R. Pijpers,et al.  Intradermal blue dye to identify sentinel lymphnode in breast cancer , 1997, The Lancet.

[4]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[5]  D. Winchester,et al.  Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulphur colloid with overnight migration time. , 1999, Journal of the American College of Surgeons.

[6]  Morton Dl.  Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? , 1997 .

[7]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[8]  Hiram S. Cody,et al.  Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. , 1998 .

[9]  H. Cody,et al.  Sentinel lymphatic mapping in breast cancer. , 1999, Journal of the American College of Surgeons.

[10]  A E Giuliano,et al.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? , 1999, Annals of surgery.

[11]  C. Eggers,et al.  CANCER OF THE BREAST , 1941, Annals of surgery.

[12]  S. Korourian,et al.  Subareolar versus peritumoral injection for location of the sentinel lymph node. , 1999, Annals of surgery.

[13]  A. Giuliano.  Guest editorial: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection , 1996, Journal of surgical oncology.

[14]  H. Cody,et al.  Lessons learned from 500 cases of lymphatic mapping for breast cancer. , 1999, Annals of surgery.

[15]  U. Veronesi,et al.  The sentinel node and breast cancer , 1999, The British journal of surgery.

[16]  K Dowlatshahi,et al.  Sentinel node biopsy in the staging of breast cancer. , 1998, American journal of surgery.

[17]  D. Weaver,et al.  Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. , 1999, Journal of the American College of Surgeons.

[18]  L. Bassett,et al.  The female breast and its disorders , 1992 .

[19]  R. Cabanas,et al.  An approach for the treatment of penile carcinoma , 1977, Cancer.

[20]  R. Turner-Warwick.  The lymphatics of the breast , 1959, The British journal of surgery.

[21]  J. W. Humphreys,et al.  Lymphatic Drainage of the Breast Demonstrated by Vital Dye Staining and Radiography , 1965, Annals of surgery.

[22]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[23]  A. Giuliano.  Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer. , 1999, Archives of surgery.

[24]  W. Montagna,et al.  Proceedings: Some neglected aspects of the anatomy of human breasts. , 1974, The Journal of investigative dermatology.

[25]  D. Reintgen,et al.  The role of sentinel lymph node biopsy in breast cancer. , 1999, Journal of the American College of Surgeons.

[26]  Donald L. Morton,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[27]  J. Guenther,et al.  Sentinel lymphadenectomy for breast cancer in a community managed care setting. , 1997, The cancer journal from Scientific American.

[28]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[29]  C. D. HAAGENSEN,et al.  Diseases of the Breast , 1972 .

[30]  J. H. Gray.  The relation of lymphatic vessels to the spread of cancer , 1939 .

[31]  Grant Rn,et al.  The surgical significance of the subareolar symph plexus in cancer of the breast. , 1953 .

[32]  H. Cody,et al.  Credentialing for breast lymphatic mapping: how many cases are enough? , 1999, Annals of surgery.

[33]  S. Wallace,et al.  Clinical applications of lymphangiography. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.

[34]  M. Riveros,et al.  Lymphadenography of the dorsal lymphatics of the penis. Technique and results , 1967, Cancer.

[35]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.